Abbott (ABT) Shares Fall as Morgan Stanley Downgrades to Equalweight
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $106.86 -0.03%
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
18 Buy, 10 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Shares of Abbott Labs (NYSE: ABT) dipped into negative territory after opening Tuesday's session higher following an early morning downgrade from Morgan Stanley.
The firm now rates Abbott shares an Equalweight, down from Overweight previously.
After gapping up 0.6 percent at the open, Abbott shares are now down 0.03 percent to $56.21.
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
The firm now rates Abbott shares an Equalweight, down from Overweight previously.
After gapping up 0.6 percent at the open, Abbott shares are now down 0.03 percent to $56.21.
For an analyst ratings summary and ratings history on Abbott Labs click here. For more ratings news on Abbott Labs click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott Labs (ABT) PT Lowered to $140 at Barclays
- Truist Securities Downgrades HashiCorp Inc (HCP) to Hold
- Barclays Downgrades Li Auto (LI) to Equalweight
Create E-mail Alert Related Categories
DowngradesRelated Entities
Morgan StanleySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
